The Big Picture
framework
What Counts as a Hypersensitivity Reaction
- An immune response that damages the host rather than only clearing a threat
- Trigger can be a harmless foreign substance (pollen, a drug) or a self-molecule
- When the target is self, the process is called autoimmunity specifically
Two Variables That Shape the Outcome
- Which arm of immunity does the damage
- Antibody-driven vs. cell-driven
- Where the target antigen sits
- Fixed in one tissue β localized disease
- Circulating or widely distributed β systemic disease
Shared Timeline Across All Four Patterns
First encounterβ
Immune system primedβ
Repeat encounterβ
Injury manifests
- Reaction is antigen-specific, not a generic overreaction
- Cross-reactive molecules can trigger the same primed response
| Pattern | Main Driver | Speed | Distribution |
|---|---|---|---|
| I | IgE + mast cells | Minutes | Local or systemic |
| II | IgG/IgM vs. fixed antigen | Hoursβdays | Tissue-specific |
| III | Circulating immune complexes | Days | Systemic, vessel-prone |
| IV | T cells | 1β3 days | Localized |
Fast & Antibody-E-Driven Reactions
Type I
Core Identity
- Only pattern built on IgE
- Symptoms appear within minutes of re-exposure
- Evolutionarily meant to expel large parasites too big to phagocytose
- About one in five people mount this response against harmless environmental triggers (pet dander, pollen) β termed atopy
How Sensitization Happens
- Antigen enters via mucosa or skin
- Helper T cells polarize toward a Th2 program
- Th2 cytokines (IL-4, IL-13) drive B cells to class-switch to IgE
- IgE coats mast cells and basophils via high-affinity Fc receptors
- On re-exposure, antigen bridges adjacent IgE molecules
- Bridging triggers degranulation
What Comes Out of the Granules
| Mediator class | Example | Effect |
|---|---|---|
| Preformed amine | Histamine | Vessel leak, smooth muscle spasm |
| Preformed enzyme | Tryptase | Local tissue remodeling |
| Lipid mediator (new) | Leukotrienes, prostaglandins | Prolonged constriction, more leak |
| Cytokine | TNF | Sustains inflammation, recruits cells |
Two Waves
Immediate wave (min)β
Late-phase wave (2β4 hr, lipid-driven)
Clinical Faces of Type I
- Allergic rhinitis β nasal edema and mucus from airborne allergens
- Asthma β bronchoconstriction and mucus plugging from inhaled triggers
- Food allergy β hives and GI upset
- Systemic anaphylaxis β widespread vasodilation, airway compromise, can be fatal
- Wheal-and-flare β the local skin reaction used diagnostically
- Anaphylaxis differs from local allergy mainly by scale: the same mediators released everywhere at once can cause vascular collapse.
Antibody vs. Surface Targets
Type II
Core Identity
- IgG or IgM binds an antigen fixed to a cell surface or extracellular matrix
- Because the target doesn't circulate, damage stays confined to that tissue
- Antigen is usually self, occasionally a foreign molecule that cross-reacts with self
Three Ways the Antibody Can Hurt
- Opsonization β faster phagocytic clearance of the coated cell
- Complement fixation β membrane attack complex or recruitment of neutrophils/macrophages
- Receptor interference β antibody blocks or stimulates a receptor without killing the cell
Two Functional Subtypes
Cytotoxic (kills the cell)
Non-cytotoxic (alters cell behavior only)
| Disease | Target | Category | Result |
|---|---|---|---|
| Autoimmune hemolytic anemia | RBC membrane proteins | Cytotoxic | Hemolysis |
| Goodpasture disease | Type IV collagen (kidney/lung basement membrane) | Cytotoxic | Nephritis + lung hemorrhage |
| Rheumatic fever | Strep antigen cross-reacting with heart | Cytotoxic | Myocarditis, arthritis |
| Transfusion reaction | ABO antigens | Cytotoxic | Acute hemolysis |
| Immune thrombocytopenia | Platelet proteins | Cytotoxic | Bleeding |
| Myasthenia gravis | Acetylcholine receptor | Non-cytotoxic (blocking) | Weakness |
| Graves disease | TSH receptor | Non-cytotoxic (stimulating) | Hyperthyroidism |
| Pernicious anemia | Intrinsic factor | Non-cytotoxic (neutralizing) | B12 malabsorption |
- Hemolytic disease of the newborn arises when an Rh-negative mother makes IgG against fetal Rh-positive red cells after a sensitizing first delivery, and that IgG crosses into a later Rh-positive pregnancy.
- Giving anti-D antibody to the mother around delivery clears fetal cells before her own B cells can form memory against them, preventing the next pregnancy's disease.
Complexes Gone Astray
Type III
Core Identity
- Antibody binds soluble antigen while still in circulation, forming a complex
- Complexes lodge wherever blood filters through narrow vessels β kidney glomeruli, joints, skin
- Damage site therefore has little to do with where the antigen originated
- Because the trigger circulates, disease tends to be systemic rather than one-organ
Injury Mechanism
Complex deposits in vessel wallβ
Complement activationβ
Neutrophil recruitmentβ
Vasculitis / nephritis / arthritis
| Disease | Antigen | Presentation |
|---|---|---|
| Systemic lupus erythematosus | Double-stranded DNA, nucleoproteins | Malar rash, nephritis, arthritis, vasculitis |
| Post-streptococcal glomerulonephritis | Strep cell-wall antigen | Granular ("lumpy-bumpy") deposits, nephritis |
| Arthus reaction | Any locally injected protein | Localized pain and edema |
| Serum sickness | Foreign serum proteins | Arthritis, vasculitis, nephritis days after exposure |
| Polyarteritis nodosa | Hepatitis B antigen | Systemic vasculitis |
Related Antinuclear-Antibody Diseases
- Diffuse systemic sclerosis β antibody to DNA topoisomerase I
- Limited scleroderma (CREST) β anti-centromere antibody
- SjΓΆgren syndrome β antibody to ribonucleoproteins
Slow-Burn T-Cell Attack
Type IV
Core Identity
- Only pattern with no antibody involvement β driven entirely by T lymphocytes
- Onset is delayed, typically one to three days after re-exposure
- Same machinery normally clears intracellular pathogens, so injury is a side effect of a legitimate defense program
Two Routes to Damage
- Cytokine-mediated
- CD4+ Th1 cells release interferon-gamma β activates macrophages
- CD4+ Th17 cells release IL-17 β recruits neutrophils
- Direct cytotoxic killing
- CD8+ cytotoxic T cells lyse the target cell directly
| Disease | T-cell target | Manifestation |
|---|---|---|
| Tuberculin skin test | Mycobacterial protein | Indurated papule |
| Contact dermatitis | Nickel, poison-ivy resin (as haptens) | Vesicular rash |
| Hashimoto thyroiditis | Thyroid antigen | Hypothyroidism |
| Multiple sclerosis | Myelin basic protein | Demyelination, visual/motor deficits |
| Rheumatoid arthritis | Joint synovium antigen | Chronic joint destruction |
| Type 1 diabetes | Islet-cell antigens | Beta-cell loss, hyperglycemia |
| Guillain-BarrΓ© syndrome | Peripheral nerve myelin | Ascending paralysis |
| Celiac disease | Gliadin-derived peptides | Small-bowel villous injury |
- Several of these diseases also produce autoantibodies (rheumatoid factor, anti-CCP, islet autoantibodies) that serve as useful lab markers even though the tissue injury itself is T-cell driven.
When Self-Recognition Fails
Autoimmunity
The Starting Point
- Autoreactive lymphocytes recognize a self-antigen, then activate, expand, and differentiate into damaging effectors
- Requires an upstream failure of central tolerance β the education process lymphocytes undergo in bone marrow and thymus
Peripheral Tolerance β the Backup System
- Anergy
- B cells: self-recognition without T-cell help drives high surface IgD, exclusion from lymphoid tissue, and eventual death
- T cells: failure of T-cell-receptor signaling, or engagement of inhibitory receptors CTLA-4 / PD-1
- Deletion
- Self-reactive T cells undergo apoptosis via caspase or Fas signaling
- Suppression
- Regulatory T cells secrete IL-10 and TGF-beta to dampen lymphocyte, macrophage, and dendritic cell activation
- Regulatory T cells express abundant CTLA-4, which sequesters the costimulatory molecule B7 away from other T cells
What Tips the Balance Toward Disease
- Genetic susceptibility β HLA alleles are the strongest known association
- Non-HLA gene polymorphisms
- Environmental triggers, including infection
- Hormonal influences
| Disease | Linked HLA allele |
|---|---|
| Rheumatoid arthritis | DR4 |
| Type 1 diabetes | DR3 / DR4 |
| Multiple sclerosis, Goodpasture | DR2 |
| Systemic lupus erythematosus | DR2 / DR3 |
| Ankylosing spondylitis, psoriasis, reactive arthritis | B27 |
| Celiac disease | DQ2 or DQ8 |
| Graves disease | B8 |
Why Autoimmune Disease Tends to Persist
- Infection or tissue damage can change how self-antigens are displayed, providing the initial trigger
- Injury to one self-antigen can expose additional self-antigens to the immune system
- This spreading exposure is why these diseases are typically chronic and progressive rather than self-limited